Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Ionis Pharmaceuticals Inc
LSE:0JDI
Ionis Pharmaceuticals Inc
LSE:0JDI
Price:
45.5788
USD
-0.27%
Market Cap:
$7.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ionis Pharmaceuticals Inc
LSE:0JDI
|
US |
|
C
|
Cleveland-Cliffs Inc
F:CVA
|
US |
|
C
|
CDL Hospitality Trusts
OTC:CDHSF
|
SG |
|
N
|
Nextera Energy Inc
F:FP3
|
US |
|
E
|
E.ON SE
SWB:EOAA
|
DE |
|
L
|
Lloyds Banking Group PLC
XETRA:LLD
|
UK |
Wall St Price Targets
0JDI Price Forecast
Based on 24 analysts
Based on 24 analysts
+93% Upside
from
$45.5788
today
Ionis Pharmaceuticals Inc (0JDI)’s 12-month stock price forecast through September 2027 has a consensus target of $88.0538, implying 93% upside. The forecast is based on price targets from 24 Wall Street analysts.
0JDI Analyst Rating
No ratings yet
No ratings yet
Ionis Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0JDI's stock price target?
Price Target
88.0538
USD
88.0538
USD
According to Wall Street analysts, the average 1-year price target for 0JDI is 88.0538 USD with a low forecast of 55.3916 USD and a high forecast of 111.9716 USD.
What is the Revenue forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
26%
26%
Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 26%.
What is the Gross Profit forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
24%
24%
The compound annual growth rate for Gross Profit over the next 8 years is 24%.